Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenCitations
Works that cite this article, indexed by OpenCitations.
The role of hepatic progenitor cells in predicting response to therapy in Egyptian patients with chronic hepatitis C, genotype 4
African Health Sciences 19(1) (2019)
Thanaa El A Helal; Nehal A Radwan; Heba A Mahmoud; Ahmed ME Zaki; Naglaa S Ahmed; Ali AA Wahib; Ahmed M Aref
Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population
Clinics and Research in Hepatology and Gastroenterology 43(5) (2019)
Amitis Ramezani; Kazem Baesi; Mohammad Banifazl; Minoo Mohraz; Farzin Khorvash; Majid Yaran; Payam Tabarsi; Amir hosein Dalirrooyfard; Fatemeh Motevalli; Anahita Bavand; Arezoo Aghakhani
Treatment Outcome in Chronic Hepatitis C Infection: A Four Years Survey Among Iranian Patients
Global Journal of Health Science 7(3) (2014)
Aliakbar Hajiaghamohammadi; Rasoul Samimi; Arash Miroliaee; Amir Mohammad Kazemifar; Masoumeh Nazem
Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline
Hepatitis Monthly 16(8) (2016)
Seyed Moayed Alavian; Behzad Hajarizadeh; Kamran Bagheri Lankarani; Heidar Sharafi; Nasser Ebrahimi Daryani; Shahin Merat; Minoo Mohraz; Masoud Mardani; Mohamad Reza Fattahi; Hossein Poustchi; Mehri Nikbin; Mahmood Nabavi; Peyman Adibi; Masood Ziaee; Bita Behnava; Mohammad Saeid Rezaee-Zavareh; Massimo Colombo; Hatef Massoumi; Abdul Rahman Bizri; Bijan Eghtesad; Majid Amiri; Ali Namvar; Khashayar Hesamizadeh; Reza Malekzadeh
Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis
Hepatitis Monthly 16(4) (2016)
Farzin Sadeghi; Mostafa Salehi-Vaziri; Amir Almasi-Hashiani; Mohammad Gholami-Fesharaki; Reza Pakzad; Seyed Moayed Alavian
Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C
Hepatitis Monthly 15(9) (2015)
Mahdiyar Pouresmaeeli; Seyed Moayed Alavian; Maryam Keshvari; Shima Salimi; Leila Mehrnoush
Predicting the Outcomes of Combination Therapy in Patients With Chronic Hepatitis C Using Artificial Neural Network
Hepatitis Monthly 14(5) (2014)
Forough Sargolzaee Aval; Nazanin Behnaz; Mohamad Reza Raoufy; Seyed Moayed Alavian
Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013
Hepatitis Monthly 13(11) (2013)
Nasser Ebrahimi Daryani; Seyed Moayed Alavian; Mohammad Hossein Somi; Mohammad Torabi-Nami
lasma Zinc Level in Hepatitis C Patients With or Without Beta Thalassemia Major; Is There Any Difference?
Hepatitis Monthly 13(8) (2013)
Mohammad Abbasinazari; Bita Behnava; Yunes Panahi; Azita Hajhossein Talasaz; Shima Salimi; Maryam Keshvari; Leila Mehrnoush; Pegah karim; Mohammad Gholami Fesharaki; Mansour Asgharinia; Seyed Moayed Alavian
Adherence to Chronic Hepatitis C Treatment Regimen: First Report From a Referral Center in Iran
Hepatitis Monthly 13(6) (2013)
Saeedeh Ravi; Mohsen Nasiri Toosi; Iman Karimzadeh; Mehdi Ahadi-Barzoki; Hossein Khalili
Some Considerations About Cardiac Toxicity of Combination Therapy for Chronic Hepatitis C
Hepatitis Monthly 13(5) (2013)
Reza Karbasi-Afshar; Amin Saburi
Efficacy and Safety of Sofosbuvir and Ribavirin for Treating Chronic Hepatitis C, Genotype 3: Experience of a Tertiary Care Hospital at Karachi, Pakistan
Cureus (2019)
Nazish Butt; Sehrish Reema; M Ali Khan; Amanullah Abbasi; Sehrish Butt; Mohammad Masood Khoso; Ali Akbar; Farhan Haleem; Ghulam Basit Mahesar; Anoshia Fahad; Talha Qureshi
Epidemiology of hepatitis C virus in Iran
World Journal of Gastroenterology 21(38) (2015)
Reza Taherkhani
Determination of Whether Vitiligo is a Contraindication to Interferon Therapy in Chronic Hepatitis C
Journal of Skin and Stem Cell 1(1) (2014)
Seyed Moayed Alavian
Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients
World Journal of Gastroenterology 21(29) (2015)
Arghavan Haj-sheykholeslami
IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C
Archives of Virology 162(1) (2016)
Parvaneh Sedighimehr; Shiva Irani; Fatemeh Sakhaee; Farzam Vaziri; Mohammadreza Aghasadeghi; Seyed Mehdi Sadat; Fatemeh Rahimi Jamnani; Abolfazl Fateh; Seyed Davar Siadat
Mutations in the NS5A gene of hepatitis C virus subtype 1b and response to peg-IFNα-2a/RBV combination therapy in Azerbaijani patients
Archives of Virology 159(11) (2014)
Farah Bokharaei-Salim; Hossein Keyvani; Mostafa Salehi-Vaziri; Farzin Sadeghi; Seyed Hamidreza Monavari; Leila Mehrnoush; Seyed Moayed Alavian
Risk Factors for Migraine Attacks in Patients Undergoing Treatment for Hepatitis C
Iranian Red Crescent Medical Journal 19(1) (2016)
Razie Salesi; Asieh Salesi; Faraidoon Haghdoost; Seyed Moayed Alavian
Psychiatric side effects of pegylated interferon‑α and ribavirin therapy in Iranian patients with chronic hepatitis C: A meta‑analysis
Experimental and Therapeutic Medicine (2018)
Lotfollah Davoodi; Babak Masoum; Mahmood Moosazadeh; Hamed Jafarpour; Mohammad Haghshenas; Tahoora Mousavi
Vitamin D in Standard HCV Regimen (PEG-Interferon Plus Ribavirin), Its Effect on the Early Virologic Response Rate: A Clinical Trial
Razavi International Journal of Medicine 4(2) (2016)
Hasan Vosoghinia; Abbas Esmaeilzadeh; Azita Ganji; Seyed Mousal-Reza Hosseini; Saeid Amel Jamehdar; Maryam Salehi; Ali Bahari; Omid Ghanaei; Maryam Sahebari; Farnood Rajabzadeh; Kamran Ghaffarzadehgan; Ladan Goshayeshi
Hepatitis C Therapy – Related Haematological Side Effects are Associated with Treatment Outcome / Hematološka Neželjena Dejstva Terapije Hepatitisa C Su Povezana Sa Ishodom Lecenja
Serbian Journal of Experimental and Clinical Research 17(1) (2016)
Vuk R. Vukovic; Dejan Baskic; Zeljko Mijailovic; Predrag Djurdjevic
The Evaluation of Interferon Lambda 4 rs368234815 as a Predictor Factor in Treated Patients with Chronic Hepatitis C Genotype 1a Infection
Indian Journal of Medical Microbiology 35(2) (2017)
Shahram Jalilian; Seyed Mahmoud Latifi; Manoochehr Makvandi; Ali Teimoori; Azarakhsh Azaran; Mehdi Parsanahad; Gholamabas Kayedani
Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNα-2a and ribavirin in Iranian patients with chronic hepatitis C
Journal of Medical Virology 86(9) (2014)
Farzin Sadeghi; Farah Bokharaei-Salim; Mostafa Salehi-Vaziri; Seyed Hamidreza Monavari; Seyed Moayed Alavian; Shima Salimi; Rouhollah Vahabpour; Hossein Keyvani